The expansion will target additional parenteral filling, device assembly and packaging capacity to support increased demand for the company’s diabetes treatment and testing products, according to a Jan. 24 Lilly news release.
Since 2020, Lilly has invested $4 billion into new manufacturing facilities in North Carolina.
“Expanding our operations at Research Triangle Park will accelerate the rate at which we can produce medicines that patients rely on to address serious health challenges like diabetes,” Edgardo Hernandez, Lilly executive vice president and president of Lilly manufacturing operations said. “We’re on track to achieve the goal we shared in November 2022 of doubling incretin capacity by the end of this year, but this investment is key to ensuring even more patients will have access to medicines they need in the future.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
